Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study

A complex interplay between β-amyloid (Aβ), Alzheimer׳s disease (AD) and major depression disorder (MDD) suggests that patients with MDD have an altered cerebral Aβ metabolism and an increased risk of developing AD. In order to elucidate the relationship between antidepressant treatment and Aβ metab...

Full description

Saved in:
Bibliographic Details
Main Authors: Kranaster, Laura (Author) , Janke, Christoph (Author) , Alonso, Angelika (Author) , Hoyer, Carolin (Author) , Frölich, Lutz (Author) , Sartorius, Alexander (Author)
Format: Article (Journal)
Language:English
Published: December 2016
In: European neuropsychopharmacology
Year: 2016, Volume: 26, Issue: 12, Pages: 1877-1884
ISSN:1873-7862
DOI:10.1016/j.euroneuro.2016.11.004
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.euroneuro.2016.11.004
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0924977X16319794
Get full text
Author Notes:Laura Kranaster, Suna Su Aksay, Jan Malte Bumb, Christoph Janke, Angelika Alonso, Carolin Hoyer, Inga Zerr, Matthias Schmitz, Lucrezia Hausner, Lutz Frölich, Alexander Sartorius

MARC

LEADER 00000caa a2200000 c 4500
001 1588441105
003 DE-627
005 20220815120141.0
007 cr uuu---uuuuu
008 190307s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.euroneuro.2016.11.004  |2 doi 
035 |a (DE-627)1588441105 
035 |a (DE-576)518441105 
035 |a (DE-599)BSZ518441105 
035 |a (OCoLC)1341041089 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kranaster, Laura  |d 1978-  |e VerfasserIn  |0 (DE-588)130370851  |0 (DE-627)500426503  |0 (DE-576)298155052  |4 aut 
245 1 0 |a Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression  |b A prospective pilot study  |c Laura Kranaster, Suna Su Aksay, Jan Malte Bumb, Christoph Janke, Angelika Alonso, Carolin Hoyer, Inga Zerr, Matthias Schmitz, Lucrezia Hausner, Lutz Frölich, Alexander Sartorius 
264 1 |c December 2016 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.03.2019 
500 |a Available online 18 November 2016 
520 |a A complex interplay between β-amyloid (Aβ), Alzheimer׳s disease (AD) and major depression disorder (MDD) suggests that patients with MDD have an altered cerebral Aβ metabolism and an increased risk of developing AD. In order to elucidate the relationship between antidepressant treatment and Aβ metabolism in humans, we performed a study on Aβ peptides in the cerebrospinal fluid (CSF) in patients with MDD during electroconvulsive therapy (ECT) as an effective antidepressant treatment. We measured the levels of Aβ1-42, Aβ1-40 and of tau proteins in the CSF in 12 patients with MDD before and after a course of ECT. Aβ1-42 was significantly elevated after the ECT treatment compared to baseline, whereas no difference was found for other peptides and proteins such as Aβ1-40, Aβ ratio, total tau protein or its phosphorylated form. The most salient finding was, that the increase of Aβ1-42 after ECT was found in all patients with clinical response to the treatment, but not in those who did not respond. The number of ECT sessions of each responding patient correlated with the increase of Aβ1-42 in the CSF. Our data point towards to a specific antidepressant mechanism which is not based on a general increase of Aβ, but seems to involve merely Aβ1-42, the isoform with highest amyloidogenic potential. We present the first study in humans demonstrating an isolated mobilization of Aβ1-42 in the CSF of patients with depression who respond to an ECT treatment. 
650 4 |a Cerebrospinal fluid 
650 4 |a CSF, Alzheimer׳s disease 
650 4 |a Depression 
650 4 |a ECT 
650 4 |a Electroconvulsive therapy 
650 4 |a β-amyloid 
700 1 |a Janke, Christoph  |d 1972-  |e VerfasserIn  |0 (DE-588)141668865  |0 (DE-627)630412162  |0 (DE-576)325043094  |4 aut 
700 1 |a Alonso, Angelika  |d 1977-  |e VerfasserIn  |0 (DE-588)1025166795  |0 (DE-627)721355315  |0 (DE-576)370025865  |4 aut 
700 1 |a Hoyer, Carolin  |d 1976-  |e VerfasserIn  |0 (DE-588)136673562  |0 (DE-627)694568090  |0 (DE-576)301202133  |4 aut 
700 1 |a Frölich, Lutz  |d 1956-  |e VerfasserIn  |0 (DE-588)1028327099  |0 (DE-627)730567516  |0 (DE-576)375813160  |4 aut 
700 1 |a Sartorius, Alexander  |d 1966-  |e VerfasserIn  |0 (DE-588)1028604793  |0 (DE-627)732049350  |0 (DE-576)376099836  |4 aut 
773 0 8 |i Enthalten in  |t European neuropsychopharmacology  |d Amsterdam : Elsevier, 1990  |g 26(2016), 12, Seite 1877-1884  |h Online-Ressource  |w (DE-627)320594025  |w (DE-600)2019305-1  |w (DE-576)266224334  |x 1873-7862  |7 nnas  |a Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression A prospective pilot study 
773 1 8 |g volume:26  |g year:2016  |g number:12  |g pages:1877-1884  |g extent:8  |a Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression A prospective pilot study 
856 4 0 |u http://dx.doi.org/10.1016/j.euroneuro.2016.11.004  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0924977X16319794  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190307 
993 |a Article 
994 |a 2016 
998 |g 1028604793  |a Sartorius, Alexander  |m 1028604793:Sartorius, Alexander  |d 60000  |e 60000PS1028604793  |k 0/60000/  |p 11  |y j 
998 |g 1028327099  |a Frölich, Lutz  |m 1028327099:Frölich, Lutz  |d 60000  |e 60000PF1028327099  |k 0/60000/  |p 10 
998 |g 136673562  |a Hoyer, Carolin  |m 136673562:Hoyer, Carolin  |d 60000  |d 62700  |e 60000PH136673562  |e 62700PH136673562  |k 0/60000/  |k 1/60000/62700/  |p 6 
998 |g 1025166795  |a Alonso, Angelika  |m 1025166795:Alonso, Angelika  |d 60000  |d 62700  |e 60000PA1025166795  |e 62700PA1025166795  |k 0/60000/  |k 1/60000/62700/  |p 5 
998 |g 141668865  |a Janke, Christoph  |m 141668865:Janke, Christoph  |d 60000  |d 61600  |e 60000PJ141668865  |e 61600PJ141668865  |k 0/60000/  |k 1/60000/61600/  |p 4 
999 |a KXP-PPN1588441105  |e 305778643X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"given":"Laura","role":"aut","family":"Kranaster","display":"Kranaster, Laura"},{"display":"Janke, Christoph","family":"Janke","given":"Christoph","role":"aut"},{"role":"aut","given":"Angelika","display":"Alonso, Angelika","family":"Alonso"},{"role":"aut","given":"Carolin","family":"Hoyer","display":"Hoyer, Carolin"},{"role":"aut","given":"Lutz","family":"Frölich","display":"Frölich, Lutz"},{"family":"Sartorius","display":"Sartorius, Alexander","role":"aut","given":"Alexander"}],"relHost":[{"titleAlt":[{"title":"ENP"}],"part":{"extent":"8","volume":"26","issue":"12","text":"26(2016), 12, Seite 1877-1884","year":"2016","pages":"1877-1884"},"language":["eng"],"disp":"Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression A prospective pilot studyEuropean neuropsychopharmacology","type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"European neuropsychopharmacology","subtitle":"ENP ; the journal of the European College of Neuropsychopharmacology","title_sort":"European neuropsychopharmacology"}],"note":["Gesehen am 31.01.20"],"origin":[{"publisherPlace":"Amsterdam","publisher":"Elsevier","dateIssuedKey":"1990","dateIssuedDisp":"1990-"}],"pubHistory":["1.1990/91 -"],"id":{"eki":["320594025"],"zdb":["2019305-1"],"issn":["1873-7862"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320594025"}],"recId":"1588441105","physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Laura Kranaster, Suna Su Aksay, Jan Malte Bumb, Christoph Janke, Angelika Alonso, Carolin Hoyer, Inga Zerr, Matthias Schmitz, Lucrezia Hausner, Lutz Frölich, Alexander Sartorius"]},"id":{"doi":["10.1016/j.euroneuro.2016.11.004"],"eki":["1588441105"]},"title":[{"title":"Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression","title_sort":"Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression","subtitle":"A prospective pilot study"}],"note":["Gesehen am 07.03.2019","Available online 18 November 2016"],"origin":[{"dateIssuedDisp":"December 2016","dateIssuedKey":"2016"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a KRANASTERLELECTROCON2016